PULMOKINE
Pulmokine is a privately held biopharmaceutical company. Our focus is on pulmonary disease and kinase inhibitor technology, hence our name Pulmokine. The mission of Pulmokine is to develop new therapies for hard-to-treat lung conditions like pulmonary arterial hypertension (PAH) and related disorders. These include pulmonary arterial fibrosis/interstitial lung disease, sarcoidosis and lung cancer.
PULMOKINE
Industry:
Biopharma Biotechnology Health Care
Founded:
2007-01-01
Address:
Rensselaer, New York, United States
Country:
United States
Website Url:
http://www.pulmokine.net
Total Employee:
51+
Status:
Active
Contact:
(518) 472-0952
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Wordpress Plugins Google Maps PHP OpenResty LayerSlider Responsive
Current Employees Featured
Larry Zisman
Larry Zisman Founder and CEO @ Pulmokine Founder and CEO
Founder
Larry Zisman
Investors List
Broadview Ventures
Broadview Ventures investment in Debt Financing - Pulmokine
Official Site Inspections
http://www.pulmokine.net Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
Loading ...